Device / Technology News

RSS

Bruker launches Icon desktop MRI systems at 2010 World Molecular Imaging Congress

At the 2010 World Molecular Imaging Congress in Kyoto, Bruker Corporation today announces the introduction of the Icon™, a new easy-to-use 1 Tesla desktop MRI scanner that combines simplicity with compact dimensions, in order to bring preclinical magnetic resonance imaging (MRI) within reach for a broader range of molecular imaging laboratories.

7 Sep 2010

Bend Research expands hot-melt extrusion pharmaceutical manufacturing capabilities

Bend Research Inc., a leading independent drug-formulation development and manufacturing company, announced today that it is expanding its pharmaceutical manufacturing capabilities for hot-melt extrusion.

7 Sep 2010

University of Maryland School of Medicine orders AVANCE III 950 US2 NMR spectrometer from Bruker

Bruker Corporation announces a major order from the University of Maryland School of Medicine for its ultra-high field AVANCE III 950 US2 NMR spectrometer. The 950 MHz Nuclear Magnetic Resonance magnet and spectrometer will help University of Maryland researchers to unravel the mysteries of molecules and develop new agents to treat cancer, AIDS and other diseases.

7 Sep 2010

miacom diagnostics presents rapid detection method for pneumonia causing pathogens

miacom diagnostics specializes on the development and production of medical tests for the detection of acute infectious diseases. In addition to its existing sepsis kits miacom, diagnostics is now presenting a further CE-marked product based on the same proprietary technology. It is targeted at the rapid detection of clinically most relevant pneumonia causing pathogens.

7 Sep 2010

Bruker announces NIST order for AVANCE III 900 NMR spectrometer

Bruker Corporation, the leader in analytical magnetic resonance instrumentation, today announces a major order from the National Institute of Standards and Technology (NIST) for its ultra-high field AVANCE™ III 900 US2 NMR spectrometer.

7 Sep 2010

Water Pik launches first line of sinus wash products

Today, Water Pik, Inc., a global leader in personal healthcare products, announced the launch of its first line of sinus wash products, Waterpik SinuSense. A brand new category for Water Pik, the SinuSense™ name introduces four products to the brand's portfolio, including the Squeeze Bottle, Neti Pot, Neti Bottle and the Water Pulsator - the first and only products of their kind in this category.

7 Sep 2010

Popularity of e cigarettes increase despite FDA's stance

Electronic cigarette sales and popularity continues to increase on a daily basis despite the US Food and Drug Administration's attempts to label the products as unsafe and untested for their intended purpose. Thousands of electronic cigarette reviews online dispute the stance of the FDA, many of them stating that the products have not only been tested, but by and large have been found to be less harmful than traditional cigarettes.

7 Sep 2010

RevMed secures contract with Medical Investment to produce fixed needle safety syringe

RevMed has secured a binding 5 Year contract to produce 5M syringes/month of its 3mL fixed needle safety syringe with Medical Investment Group, LLC (MIG). MIG, a Massachusetts Limited Liability Company, will fulfill this obligation through its relationship with an internationally certified global medical device manufacturer.

7 Sep 2010

FDA grants IRIS clearance for analysis of synovial fluid with iQ200, iRICELL automated microscopy analyzers

IRIS International, Inc., a leading manufacturer of automated in-vitro diagnostic systems and consumables for use in hospitals and commercial laboratories worldwide and provider of high value personalized diagnostics testing services through its CLIA certified molecular diagnostics laboratory, today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the analysis of synovial fluid as a new product application in its Body Fluids Module utilizing its iQ®200 and iRICELL® automated microscopy analyzers.

7 Sep 2010

Medtronic announces international launch of Resolute Integrity Stent System

Medtronic, Inc. (NYSE: MDT), announces the CE (Conformite Europeene) mark and international launch of the Resolute Integrity Stent System for the treatment of coronary artery disease, a leading cause of death and poor quality of life.

7 Sep 2010

DSM, PolyTherics enter agreement for HiPEG IFN alpha-2a product development

DSM BioSolutions, DSM's microbial fermentation CMO business unit and PolyTherics Limited an innovator in precision engineering of proteins, today announced that they have entered into an agreement for the process development and manufacture of PolyTherics' lead biobetter product, HiPEG IFN alpha-2a.

7 Sep 2010

International Iberian Nanotechnology Laboratory orders for Vistec's EBPG5200 electron-beam lithography system

Vistec Lithography, a leading supplier of advanced electron-beam lithography systems has announced today that the International Iberian Nanotechnology Laboratory (INL) in Braga, Portugal has placed an order for Vistec's electron-beam lithography system EBPG5200. The Portuguese Laboratory is the first fully international research organization in Europe in the field of nanoscience and nanotechnology.

7 Sep 2010

Ultrasound guidance helps radiologist to identify, treat self-embedding patients

Using ultrasound and a minimally-invasive procedure, radiologists can identify and treat patients who engage in a disturbing self-injury behavior known as self-embedding, according to a new study published in the online edition and October print issue of the journal Radiology.

7 Sep 2010

Researchers decode words from brain signals in paralyzed people

In an early step toward letting severely paralyzed people speak with their thoughts, University of Utah researchers translated brain signals into words using two grids of 16 microelectrodes implanted beneath the skull but atop the brain. "We have been able to decode spoken words using only signals from the brain with a device that has promise for long-term use in paralyzed patients who cannot now speak," says Bradley Greger, an assistant professor of bioengineering.

7 Sep 2010

Myconostica's MycAssay Aspergillus for serum granted CE marking

Myconostica Ltd, the UK-based medical diagnostic company developing and commercialising rapid and highly specific tests for life-threatening fungal infections, today announces the CE marking of its lead product MycAssay™ Aspergillus for detection of Aspergillus DNA in serum.

6 Sep 2010

PennHIP radiographic method may hold potential to evaluate human susceptibility to hip dysplasia

A study comparing a University of Pennsylvania method for evaluating a dog's susceptibility to hip dysplasia to the traditional American method has shown that 80 percent of dogs judged to be normal by the traditional method are actually at risk for developing osteoarthritis and hip dysplasia, according to the Penn method.

4 Sep 2010

Exmovere commences development of urban electric vehicle for active women

Exmovere Holdings, Inc., a biomedical engineering company, today announced that it is developing a stand and ride road vehicle to complement its Chariot product line, called the "Red Fury." On June 22nd of this year, Exmovere Holdings engaged Sarah Park as lead industrial designer for this product. The Red Fury is an urban electric vehicle that is based on Sarah Park's unique trapezoid-based design language and is intended to supplant mopeds and electric bicycles.

4 Sep 2010

Study suggest PET/CT scanning may offer effective breast cancer detection, spread

About one-third of women diagnosed with early-stage breast cancer will have their cancer travel, or metastasize, to other parts of the body, with the bone being the most common site of initial detectable spread. Controversy continues to surround the question of whether CT and bone scans should be standard in evaluating patients for these metastases, or whether integrated PET/CT scanning might be more effective at detecting breast tumors that have reached nearby bones.

4 Sep 2010

MSKCC develops new prediction tool to calculate risk for DCIS recurrence after breast-conserving surgery

The decision regarding treatment following breast-conserving surgery for patients diagnosed with ductal carcinoma in-situ (DCIS) has long been an area of discussion and confusion for patients and physicians alike. While the mortality rates for DCIS remain low, the risk of local recurrence in the breast is high. Standard treatments following surgery include radiation therapy and hormone treatment.

4 Sep 2010

FDA approves IDE study to evaluate HeartWare Ventricular Assist System

HeartWare International, Inc., a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, today announced that the U.S. Food and Drug Administration (FDA) has approved an IDE (Investigational Device Exemption) Supplement that allows HeartWare to enroll a second allotment of 54 patients in its "ADVANCE" bridge-to-transplant clinical trial under a Continued Access Protocol (CAP).

4 Sep 2010

Device / Technology News

Bruker launches Icon desktop MRI systems at 2010 World Molecular Imaging Congress

Bend Research expands hot-melt extrusion pharmaceutical manufacturing capabilities

University of Maryland School of Medicine orders AVANCE III 950 US2 NMR spectrometer from Bruker

miacom diagnostics presents rapid detection method for pneumonia causing pathogens

Bruker announces NIST order for AVANCE III 900 NMR spectrometer

Water Pik launches first line of sinus wash products

Popularity of e cigarettes increase despite FDA's stance

RevMed secures contract with Medical Investment to produce fixed needle safety syringe

FDA grants IRIS clearance for analysis of synovial fluid with iQ200, iRICELL automated microscopy analyzers

Medtronic announces international launch of Resolute Integrity Stent System

DSM, PolyTherics enter agreement for HiPEG IFN alpha-2a product development

International Iberian Nanotechnology Laboratory orders for Vistec's EBPG5200 electron-beam lithography system

Ultrasound guidance helps radiologist to identify, treat self-embedding patients

Researchers decode words from brain signals in paralyzed people

Myconostica's MycAssay Aspergillus for serum granted CE marking

PennHIP radiographic method may hold potential to evaluate human susceptibility to hip dysplasia

Exmovere commences development of urban electric vehicle for active women

Study suggest PET/CT scanning may offer effective breast cancer detection, spread

MSKCC develops new prediction tool to calculate risk for DCIS recurrence after breast-conserving surgery

FDA approves IDE study to evaluate HeartWare Ventricular Assist System

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest News